ANVS Annovis Bio, Inc. Common Stock
$1.81
价格 · 八月 25, 2026
截至...的财报数据 八月 14, 2026
ANVS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.80
市值
$49M
P/E (TTM)
-1.3
每股收益 (TTM)
$-1.40
营收 (TTM)
$0
股息收益率
—
ROE
-164.0%
负债/权益
—
52周区间
$2 – $6
ANVS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2019-12-31
→
2025-12-31
EPS
$-1.40
2020-12-31
→
2025-12-31
自由现金流
—
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ANVS
同行中位数
P/E (TTM)
-1.3
4.7
P/B (市净率)
2.9
1.8
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ANVS
同行中位数
ROA
-164.8%
-68.1%
ROE
-164.0%
-111.7%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ANVS
同行中位数
Quick Ratio (速动比率)
5.4
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ANVS
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ANVS
同行中位数
ANVS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
9 位分析师
- 强烈买入 2 22.2%
- 买入 6 66.7%
- 持有 1 11.1%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
3 位分析师 · 2026-08-24
中位数
$8.00
平均值
$11.00
← 低于所有目标
$1.80
最低
$8.00
最高
$17.00
中位数目标
$8.00
+343.2%
平均目标
$11.00
+509.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.04%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.63 | $-0.40 | -0.23% |
| 2025年12月31日 | $-0.39 | $-0.35 | -0.04% |
| 2025年9月30日 | $-0.37 | $-0.31 | -0.06% |
| 2025年6月30日 | $-0.32 | $-0.41 | 0.09% |
| 2025年3月31日 | $-0.32 | $-0.36 | 0.04% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ANVS | $94M | -2.5 | — | — | -164.0% | — |
| DWTX | $124M | -0.6 | 123.6% | — | -83.8% | — |
| ELTX | — | -3.1 | — | — | — | — |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | — |
| FRMM | — | — | — | -6881.3% | -368.1% | — |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | — |
| RNTX | — | -0.6 | — | — | — | — |
| NMAD | — | — | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $25M | $20M | $39M | $17M | $8M | $3M | $776.3K | |
| SG&A Expense | $4M | $7M | $6M | $9M | $6M | $4M | $829.4K | |
| Operating Expenses | $30M | $27M | $45M | $26M | $15M | $7M | $2M | |
| Operating Income | $-30M | $-27M | $-45M | $-26M | $-15M | $-7M | $-2M | |
| Interest Income | $699.1K | $331.8K | $667.9K | · | · | · | · | |
| Other Non-op | $841.1K | $2M | $-11M | $182.7K | $50.1K | $1M | $614.6K | |
| Pretax Income | · | · | $-56M | $-25M | $-14M | $-5M | $-991.0K | |
| Income Tax | $0 | · | · | · | · | · | $0 | |
| Net Income | $-29M | $-25M | $-56M | $-25M | $-14M | $-5M | $-991.0K | |
| EPS (Basic) | $-1.40 | $-2.02 | $-6.23 | $-3.10 | $-1.90 | $-0.87 | · | |
| EPS (Diluted) | $-1.40 | $-2.31 | $-6.23 | $-3.10 | $-1.90 | $-0.87 | · | |
| Shares (Basic) | 20,551,997 | 12,182,475 | 9,023,138 | 8,162,326 | 7,626,278 | 6,308,961 | · | |
| Shares (Diluted) | 20,551,997 | 12,235,444 | 9,023,138 | 8,162,326 | 7,626,278 | 6,308,961 | · | |
| EBITDA | $-30M | $-27M | $-45M | $-26M | $-15M | $-7M | · |
资产负债表 12
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $11M | $6M | $28M | $46M | $8M | $1.9K | |
| Current Assets | · | · | $10M | $36M | $46M | $8M | $747.5K | |
| Total Assets | $21M | $14M | $10M | $36M | $46M | $8M | $1M | |
| Accounts Payable | $3M | $2M | $1M | $4M | $688.1K | $341.9K | $1M | |
| Current Liabilities | $4M | $4M | $4M | $8M | $2M | $578.4K | $2M | |
| Total Liabilities | $4M | $5M | $18M | $8M | $2M | $578.4K | $3M | |
| Common Stock | $2.7K | $1.4K | $1.1K | $816 | $810 | $689 | $28 | |
| Paid-in Capital | $181M | $144M | $103M | $82M | $73M | $22M | $200.6K | |
| Retained Earnings | $-164M | $-135M | $-110M | $-54M | $-29M | $-14M | $-9M | |
| Stockholders' Equity | $17M | $9M | $-8M | $28M | $44M | $8M | $-9M | |
| Liabilities + Equity | $21M | $14M | $10M | $36M | $46M | $8M | $1M | |
| Shares Outstanding | 27,199,139 | 14,141,521 | 10,519,933 | 8,163,923 | 8,100,570 | 6,891,608 | 282,614 |
现金流 6
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $4M | $5M | $9M | $5M | $2M | $8.5K | |
| Operating Cash Flow | $-26M | $-22M | $-40M | $-17M | $-9M | $-4M | $-476.5K | |
| Stock Issued | · | $19M | $17M | · | $47M | $12M | · | |
| Net Stock Activity | · | $19M | $17M | · | $47M | $12M | · | |
| Financing Cash Flow | $35M | $27M | $17M | $4.6K | $47M | $12M | $443.1K | |
| Net Change in Cash | $9M | $5M | $-23M | $-17M | $38M | $8M | $-33.5K |
盈利能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -164.8% | -203.8% | -243.2% | -69.3% | -53.5% | -118.3% | · | |
| ROE | -164.0% | -300.4% | 10287.8% | -80.5% | -31.8% | -65.6% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 2.4 | 4.7 | 30.5 | 14.0 | · | |
| Quick Ratio | 5.4 | 2.7 | 1.3 | 3.7 | 30.3 | 14.0 | · |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-29M | $-25M | $-56M | $-25M | $-14M | $-5M | $-991.0K | |
| Market Cap | $94M | $71M | $197M | $110M | $142M | $52M | · | |
| P/E | -2.5 | -2.2 | -3.0 | -4.3 | -9.3 | -8.7 | · | |
| P/B | 5.6 | 7.6 | -25.4 | 3.9 | 3.2 | 6.9 | · | |
| P / Tangible Book | 5.6 | 7.6 | · | 3.9 | 3.2 | 6.9 | · | |
| P / Cash Flow | -3.7 | -3.2 | -4.9 | -6.3 | -15.6 | -13.1 | · | |
| Earnings Yield | -40.5% | -45.9% | -33.3% | -23.1% | -10.8% | -11.5% | · |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| R&D Expense | $12M | $17M | $9M | $6M | $5M | $5M | $5M | $3M | $6M | $7M | $9M | $14M | $8M | $8M | $6M | $4M | |
| SG&A Expense | $2M | $1M | $955.2K | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | |
| Operating Expenses | $14M | $18M | $10M | $7M | $6M | $6M | $7M | $4M | $8M | $8M | $10M | $15M | $10M | $10M | $8M | $6M | |
| Operating Income | $-14M | $-18M | $-10M | $-7M | $-6M | $-6M | $-7M | $-4M | $-8M | $-8M | $-10M | $-15M | $-10M | $-10M | $-8M | $-6M | |
| Interest Income | $160.2K | $137.8K | $167.7K | $152.3K | $191.4K | $187.6K | $126.3K | $135.4K | $26.0K | $44.2K | $66.1K | $146.7K | · | · | · | · | |
| Other Non-op | $-443.1K | $405.8K | $-128.3K | $172.3K | $51.4K | $745.6K | $870.2K | $-8M | $3M | $7M | $-12M | $146.7K | $222.6K | $232.5K | $74.2K | $52.9K | |
| Pretax Income | · | · | · | · | · | · | · | $-13M | $-5M | $-1M | · | $-15M | $-10M | $-10M | $-8M | $-6M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income | $-15M | $-18M | $-10M | $-7M | $-6M | $-6M | $-6M | $-13M | $-5M | $-1M | $-22M | $-15M | $-10M | $-10M | $-8M | $-6M | |
| EPS (Basic) | $-0.40 | $-0.63 | $-0.39 | $-0.37 | $-0.32 | $-0.32 | $-0.51 | $-0.97 | $-0.44 | $-0.10 | $-2.34 | $-1.63 | $-1.07 | $-1.19 | $-0.94 | $-0.79 | |
| EPS (Diluted) | $-0.40 | $-0.63 | $-0.39 | $-0.37 | $-0.32 | $-0.32 | $-0.18 | $-0.97 | $-0.44 | $-0.72 | $-2.46 | $-1.63 | $-1.07 | $-1.07 | $-0.94 | $-0.79 | |
| Shares (Basic) | 37,518,778 | 27,847,884 | -36,050,539 | 19,685,071 | 19,486,231 | 17,431,234 | -22,726,157 | 12,975,808 | 11,307,759 | 10,625,065 | -17,135,434 | 9,012,273 | 8,951,309 | 8,194,990 | -16,322,965 | 8,163,923 | |
| Shares (Diluted) | 37,518,778 | 27,847,884 | -36,050,539 | 19,685,071 | 19,486,231 | 17,431,234 | -22,872,894 | 12,975,808 | 11,307,759 | 10,824,771 | -17,891,753 | 9,012,273 | 8,951,309 | 8,951,309 | -16,322,965 | 8,163,923 | |
| EBITDA | $-14M | $-18M | · | $-7M | · | $-6M | · | $-4M | $-8M | $-8M | · | $-15M | $-10M | $-10M | · | $-8M |
资产负债表 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $14M | $20M | $15M | $17M | $22M | $11M | $13M | $4M | $3M | $6M | $6M | $16M | $17M | $28M | $32M | |
| Current Assets | · | · | · | · | · | · | · | · | · | $8M | · | $10M | $23M | $26M | $36M | $32M | |
| Total Assets | $22M | $16M | $21M | $17M | $21M | $27M | $14M | $14M | $5M | $8M | $10M | $10M | $23M | $26M | $36M | $32M | |
| Accounts Payable | $3M | $5M | $3M | $2M | $974.3K | $1M | $2M | $4M | $3M | $4M | $1M | $2M | $1M | $4M | $4M | $2M | |
| Current Liabilities | $6M | $13M | $4M | $4M | $3M | $3M | $4M | $5M | $4M | $5M | $4M | $4M | $2M | $5M | $8M | $3M | |
| Total Liabilities | $26M | $13M | $4M | $4M | $3M | $3M | $5M | $7M | $7M | $11M | $18M | $4M | $2M | $5M | $8M | $3M | |
| Common Stock | $4.3K | $2.9K | $2.7K | $2.0K | $1.9K | $1.9K | $1.4K | $1.3K | $1.2K | $1.1K | $1.1K | $902 | $902 | $822 | $816 | $816 | |
| Paid-in Capital | $192M | $184M | $181M | $167M | $165M | $164M | $144M | $136M | $115M | $108M | $103M | $95M | $94M | $84M | $82M | $81M | |
| Retained Earnings | $-196M | $-181M | $-164M | $-154M | $-147M | $-140M | $-135M | $-129M | $-116M | $-111M | $-110M | $-88M | $-73M | $-64M | $-54M | $-51M | |
| Stockholders' Equity | $-4M | $3M | $17M | $13M | $18M | $24M | $9M | $7M | $-2M | $-3M | $-8M | $7M | $21M | $20M | $28M | $30M | |
| Liabilities + Equity | $22M | $16M | $21M | $17M | $21M | $27M | $14M | $14M | $5M | $8M | $10M | $10M | $23M | $26M | $36M | $32M | |
| Shares Outstanding | 42,606,152 | 28,537,302 | 27,199,139 | 20,187,904 | 19,486,231 | 19,486,231 | 14,141,521 | 13,283,667 | 11,721,480 | 11,011,299 | 10,519,933 | 9,012,273 | 9,012,273 | 8,216,678 | 8,163,923 | 8,163,923 |
现金流 6
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $182.8K | $356.5K | $444.6K | $496.6K | $499.9K | $1M | $393.1K | $2M | $364.8K | $882.4K | $632.2K | $2M | $2M | $1M | $2M | |
| Operating Cash Flow | $-22M | $-9M | $-9M | $-3M | $-5M | $-8M | $-8M | $-3M | $-3M | $-7M | $-9M | $-9M | $-10M | $-12M | $-4M | $-4M | |
| Stock Issued | · | · | · | · | · | · | · | $4M | $4M | $4M | $8M | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $4M | · | · | · | · | · | · | |
| Financing Cash Flow | $26M | $4M | $13M | $2M | $0 | $20M | $6M | $12M | $4M | $4M | $9M | $0 | $9M | $7.4K | $0 | $0 | |
| Net Change in Cash | $5M | $-5M | $4M | $-2M | $-5M | $12M | $-2M | $9M | $860.8K | $-3M | $-600.2K | $-9M | $-1M | $-12M | $-4M | $-4M |
盈利能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -68.2% | -81.9% | · | -46.0% | · | -32.0% | · | -102.8% | -36.0% | -6.4% | · | -68.9% | -32.1% | -28.3% | · | -19.0% | |
| ROE | -210.6% | -129.6% | · | -71.8% | · | -53.5% | · | -184.2% | -52.9% | -12.7% | · | -80.4% | -34.1% | -31.3% | · | -19.9% | |
| ROIC | · | · | · | · | · | · | · | -62.1% | 443.4% | 232.8% | · | -223.2% | -47.0% | -49.5% | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | · | · | · | · | 1.6 | · | 2.9 | 11.0 | 4.7 | · | 12.9 | |
| Quick Ratio | 2.9 | 1.1 | · | 4.1 | · | 8.9 | · | 2.3 | 1.0 | 0.6 | · | 1.8 | 7.6 | 3.1 | · | 12.7 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | 0.0 | · | · | · | 0.0 | · | · | · | 0.0 | · | · |
估值 (TTM) 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-46M | $-37M | · | $-32M | $-29M | $-24M | · | $-33M | $-30M | $-35M | · | $-40M | $-32M | $-27M | · | $-20M | |
| Market Cap | $79M | $64M | · | $42M | · | $29M | · | $107M | $68M | $131M | · | $86M | $129M | $127M | · | $112M | |
| P/E | -1.1 | -1.4 | · | -1.0 | -1.1 | -0.6 | · | -2.1 | -1.5 | -2.7 | · | -2.1 | -3.9 | -4.8 | · | -5.5 | |
| P/B | -18.6 | 20.4 | · | 3.2 | · | 1.2 | · | 15.2 | -38.6 | -39.1 | · | 12.8 | 6.2 | 6.3 | · | 3.7 | |
| P / Tangible Book | · | 20.4 | · | 3.2 | 2.3 | 1.2 | · | 15.2 | · | · | · | 12.8 | 6.2 | 6.3 | · | 3.7 | |
| P / Cash Flow | · | -7.1 | · | · | · | -3.6 | · | · | · | -18.6 | · | · | · | -10.9 | · | · | |
| Earnings Yield | -92.5% | -73.5% | · | -95.7% | -94.5% | -163.3% | · | -46.7% | -67.0% | -37.7% | · | -48.0% | -25.6% | -21.0% | · | -18.3% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| 收入 | $0 | $0 | $0 | $0 | — |
| 净收入 | $-29M | $-25M | $-56M | $-25M | — |
| 稀释后每股收益 (EPS) | $-1.40 | $-2.31 | $-6.23 | $-3.10 | — |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| 流动比率 | — | — | 2.4 | 4.7 | — |
| 速动比率 | 5.4 | 2.7 | 1.3 | 3.7 | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 73 家申报者 · $18.8M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 16 (+2 与上一季度对比) | 11 (+4 与上一季度对比) | 21 (+6 与上一季度对比) | 7 (-3 与上一季度对比) | +5.8M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 9 位内幕人士 · 4 位高管 · 6 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Maria-Luisa Maccecchini | President & CEO | 2025年10月28日 P | 1212020 | 1 | 0 | $200000 |
| Henry Hagopian III | Chief Financial Officer | 2023年11月20日 A | 1820 | 0 | 0 | $0 |
| Jeffrey Brian Mcgroarty | Chief Financial Officer | 2022年1月3日 A | 52833 | 0 | 0 | $0 |
| Andrew Walsh | Vice President, Finance | 2025年6月16日 A | 500 | 0 | 0 | $0 |
| Michael B Hoffman | 董事 | 2026年5月20日 P | 3364883 | 18 | 0 | $4256887 |
| Claudine Bruck | 董事 | 2025年9月10日 M | 13709 | 0 | 0 | $0 |
| Reid Mccarthy | 董事 | 2025年6月10日 A | 9305 | 0 | 0 | $0 |
| Mark K. White | 董事 | 2024年7月1日 A | 61167 | 0 | 0 | $0 |
| Jr. Robert M. Whelan, | 董事 | 2020年7月1日 A | 95700 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Maria L. Maccecchini | 2020年4月20日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 4 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。